Compare Payoneer Global Inc (PAYO) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Payoneer Global Inc vs Tempus AI — how do they compare? Payoneer Global Inc trades at $7.19 (market cap $2.43B), while Tempus AI trades at $70.35 (market cap $12.77B). The key difference: Tempus AI is far larger — about 5.3× Payoneer Global Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Payoneer Global Inc for 61 Days and Tempus AI for 22 Days on average.
| PAYO | TEM | |
|---|---|---|
Market Cap | $2.43B | $12.77B |
Volume | 1,601,413 | 8,980,490 |
Sector | Technology | Broad Market / Factor |
52-Week High | $7.18 | $99.28 |
52-Week Low | $4.27 | $41.55 |
Typical Hold Time | 61 Days | 22 Days |
Enterprise Value | $2.17B | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Payoneer Global (PAYO) trades at $7.16, up 0.14% with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating Q1 2026 estimates but missing Q2 2026. Revenue grew to $821M in 2025, though net income margin compressed to 5.83%. Recent news highlights Payoneer's renewed partnership with Etsy through 2029 and a pending acquisition by Nuvei announced in June 2026.
The outlook is clouded by earnings volatility and acquisition uncertainty, but analyst sentiment remains positive with 60% buy ratings. Key risks include integration challenges post-acquisition and competitive pressures in fintech. The stock's elevated P/E of 51.14 suggests growth expectations must materialize to justify valuation.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
